Neoantigen cancer vaccine (individualized)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neoantigen cancer vaccine (individualized), covering 2024-12-31 to 2024-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer [Phase 2]